Chen Zhiyong, Kwek Jia Liang, Lim Ru Sin, Yong Yan Rong, Loh Alwin Hwai Liang, Lim Weng Khong, Teo Jing Xian, Tay Karine Su Shan, Ng Peng Soon
Department of Neurology, National Neuroscience Institute (Tan Tock Seng Hospital Campus), 11 Jalan Tan Tock Seng, Singapore, 308433, Singapore.
Department of Renal Medicine, Singapore General Hospital, Singapore, Singapore.
BMC Neurol. 2025 May 6;25(1):199. doi: 10.1186/s12883-025-04210-8.
The Kleefstra syndrome spectrum (KSS) is a group of neurodevelopmental disorders characterized by intellectual disability, behavioral disorders, growth and neurodevelopmental delay, facial dysmorphism and neurological deficits. Kleefstra syndrome 2 (KLEFS2) is a part of KSS and is due to heterozygous loss-of-function variants in the KMT2 C gene. We report the long-term clinical course and multi-organ manifestations of a patient with KLEFS2 caused by a novel heterozygous pathogenic variant in KMT2 C.
A patient with KSS phenotype developed proteinuria with progressive kidney dysfunction secondary to focal segmental glomerular sclerosis. She subsequently developed recurrent episodes that mimicked mitochondrial stroke-like episodes. The phenotype included encephalopathy, stroke-like episodes with focal status epilepticus with impaired consciousness associated with cortical and subcortical T2/FLAIR signal hyperintensities that partially responded to intravenous arginine infusions.
Exome sequencing revealed a heterozygous pathogenic nonsense variant in KMT2 C (NM_170606.3) c.3940C > T (p.Gln1314Ter). Nuclear and mitochondrial DNA variants associated with mitochondrial disorders have been excluded.
This is a case of KLEFS2 with longitudinal 10 year follow up and its previously unreported multi-organ clinical manifestations including stroke-like episodes and nephrotic disease. Our report further expands the phenotypic spectrum of KLEFS2. Further reports of patients with KLEFS2 with multi-organ involvement should be sought to confirm our findings.
克莱夫斯特拉综合征谱系(KSS)是一组神经发育障碍,其特征为智力残疾、行为障碍、生长和神经发育迟缓、面部畸形及神经功能缺损。克莱夫斯特拉综合征2型(KLEFS2)是KSS的一部分,由KMT2C基因的杂合功能丧失变异所致。我们报告了一名因KMT2C基因新型杂合致病变异导致的KLEFS2患者的长期临床病程及多器官表现。
一名具有KSS表型的患者出现蛋白尿,并继发局灶节段性肾小球硬化导致进行性肾功能不全。她随后出现反复发作,类似线粒体中风样发作。其表型包括脑病、伴有意识障碍的局灶性癫痫持续状态的中风样发作,伴有皮质和皮质下T2/FLAIR信号高增强,静脉输注精氨酸后部分症状有所缓解。
外显子组测序揭示KMT2C(NM_170606.3)存在杂合致病变异c.3940C>T(p.Gln1314Ter)。已排除与线粒体疾病相关的核DNA和线粒体DNA变异。
这是一例随访10年的KLEFS2病例,其多器官临床表现包括中风样发作和肾病此前未被报道。我们的报告进一步扩展了KLEFS2的表型谱。应寻求更多KLEFS2多器官受累患者的报告以证实我们的发现。